Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Restructuring Costs (2017 - 2025)

Historic Restructuring Costs for Fresenius Medical Care AG (FMS) over the last 10 years, with Q1 2025 value amounting to $85.2 million.

  • Fresenius Medical Care AG's Restructuring Costs rose 46020.95% to $85.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $170.6 million, marking a year-over-year increase of 11442.91%. This contributed to the annual value of $60.9 million for FY2024, which is 18449.39% up from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Restructuring Costs of $85.2 million as of Q1 2025, which was up 46020.95% from $60.9 million recorded in Q4 2024.
  • Over the past 5 years, Fresenius Medical Care AG's Restructuring Costs peaked at $85.2 million during Q1 2025, and registered a low of -$595.8 million during Q4 2022.
  • Its 5-year average for Restructuring Costs is -$126.5 million, with a median of $466106.3 in 2024.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Restructuring Costs crashed by 1249.22% in 2022, and later soared by 46020.95% in 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Restructuring Costs (Quarter) stood at -$529.7 million in 2021, then fell by 12.49% to -$595.8 million in 2022, then soared by 87.9% to -$72.1 million in 2023, then skyrocketed by 184.49% to $60.9 million in 2024, then surged by 39.88% to $85.2 million in 2025.
  • Its Restructuring Costs was $85.2 million in Q1 2025, compared to $60.9 million in Q4 2024 and -$14.3 million in Q3 2024.